do not combine dpp-4 inhibitor with glp-1 receptor agonist guideline agonists inhibitors The effect of DPP Neuroprotection by dipeptidyl-peptidase-4 inhibitors and
Description
Zhu, J., et al

A Cautionary Account that GLP-1 Receptor Agonists May be Too Effective for Unmonitored Weight Loss

S., Fussman, C., & Imes, G

Of note, she previously had gastroesophageal reflux disease, but these symptoms had resolved since she started tirzepatide (Mounjaro, Eli Lilly, Indianapolis, IN) 12.5 mg/0.5 mL pen injector injection (last dose 2 days before surgery)

Balkrishna Chaube, Yale University, United States
Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity
00174-1/asset/4ff9bb50-3a8f-4946-a683-db1579705072/main.assets/gr1.jpg)